Fortrea Holdings Past Earnings Performance
Past criteria checks 0/6
Fortrea Holdings has been growing earnings at an average annual rate of 55.2%, while the Life Sciences industry saw earnings growing at 19.7% annually. Revenues have been growing at an average rate of 2.2% per year.
Key information
55.2%
Earnings growth rate
-154.1%
EPS growth rate
| Life Sciences Industry Growth | 12.9% |
| Revenue growth rate | 2.2% |
| Return on equity | -5.7% |
| Net Margin | -3.0% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Fortrea Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 3,077 | -91 | 340 | 0 |
| 31 Dec 23 | 3,109 | -3 | 337 | 0 |
| 30 Sep 23 | 3,025 | 57 | 334 | 0 |
| 30 Jun 23 | 3,011 | 130 | 326 | 0 |
| 31 Mar 23 | 3,011 | 168 | 322 | 0 |
| 31 Dec 22 | 3,096 | 193 | 280 | 0 |
| 31 Dec 21 | 3,058 | 98 | 303 | 0 |
| 31 Dec 20 | 2,580 | -359 | 268 | 0 |
Quality Earnings: FTRE1 * is currently unprofitable.
Growing Profit Margin: FTRE1 * is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: FTRE1 * is unprofitable, but has reduced losses over the past 5 years at a rate of 55.2% per year.
Accelerating Growth: Unable to compare FTRE1 *'s earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: FTRE1 * is unprofitable, making it difficult to compare its past year earnings growth to the Life Sciences industry (-1.7%).
Return on Equity
High ROE: FTRE1 * has a negative Return on Equity (-5.73%), as it is currently unprofitable.